L’Agenzia Italiana del Farmaco, in accordo con l’Agenzia Europea dei
Medicinali, rende disponibili nuove ed importanti informazioni riguardo l’errore presente nel paragrafo 3 nel Foglio Illustrativo dei medicinali Irbesartan / Idroclorotiazide Teva.
Reports of severe dehydration and changes in the levels of serum electrolytes from taking more than the recommended dose, resulting in serious adverse effects, in some cases resulting in death.
If a consumer were not to notice the incorrect unit of measure, it is possible that the meter result could be read as a lower than expected blood glucose result.
The fiber filter or the sealing compound, holding the fiber in place, could break apart, exposing patients to bacteria or viruses, which could result in infection or death.
Promotional materials for non-medical water filtration products were determined to promote claims which constitute marketing the product as a medical device.
If infused, particulate matter may result in blockages of blood vessels, which can result in stroke, heart attack, or damage to other organs such as the kidney or liver.
L’Agenzia Italiana del Farmaco, in accordo con l’Agenzia Europea dei
Medicinali, rende disponibili nuove informazioni sull’importanza di dimostrare lo stato senza mutazioni (wild type) di RAS (esoni 2, 3 e 4 di KRAS e NRAS) prima del trattamento con Erbitux® (cetuximab).
80.211.154.110
